Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EP300 | Q09472 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 2/20 | 0.34 |
| ▸ | CA1 | P00915 | 2/20 | 0.33 |
| ▸ | FAAH | O00519 | 2/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11973011 | 1.00 | EP300 (0.41) | EP300TSHRCA1FAAHMEN1 | |
| SCHEMBL28732825 | 0.93 | GRIK1 (0.34) | EP300TSHRCA1 | |
| SCHEMBL11973156 | 0.82 | EP300 (0.43) | EP300TSHRCA1 | |
| SCHEMBL11973153 | 0.82 | EP300 (0.43) | EP300TSHRCA1 | |
| SCHEMBL11972801 | 0.80 | EP300 (0.47) | EP300TSHR | |
| SCHEMBL11972799 | 0.80 | EP300 (0.47) | EP300TSHR | |
| SCHEMBL11973490 | 0.80 | EP300 (0.42) | EP300TSHRCA1MEN1CYP3A4 | |
| SCHEMBL11973489 | 0.80 | EP300 (0.42) | EP300TSHRCA1MEN1CYP3A4 | |
| SCHEMBL24942590 | 0.79 | EP300 (0.32) | EP300 | |
| SCHEMBL11973094 | 0.78 | EP300 (0.45) | EP300TSHRFAAHMEN1CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2678410-B1 | COMPOSIITONS COMPRISING MIXTURES OF C10-C13 ALKYLPHENYL SULFONATES | PROCTER & GAMBLE (US) | 2017-09-13 | — | — | EP | disclosed |
| US-9193937-B2 | Mixtures of C10-C13 alkylphenyl sulfonates | THE PROCTER & GAMBLE COMPANY (US) | 2015-11-24 | — | — | US | disclosed |
| WO-2012138423-A1 | COMPOSITIONS COMPRISING MIXTURES OF C10-C13 ALKYLPHENYL SULFONATES | THE PROCTER & GAMBLE COMPANY (US) | 2012-10-11 | — | — | WO | disclosed |
| US-20120214724-A1 | Mixtures OF C10-C13 Alkylphenyl Sulfonates | THE PROCTER & GAMBLE COMPANY | 2012-08-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120214724-A1 | Mixtures OF C10-C13 Alkylphenyl Sulfonates | SMURF1, C1S, SMURF2 | EP300 121/4885TSHR 2411/4885CA1 3196/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.